TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474 | -80.9% | 56,660 | -43.3% | 0.02% | -79.6% |
| Q2 2023 | $2,482 | +351.3% | 99,931 | +173.2% | 0.11% | +315.4% |
| Q1 2023 | $550 | -75.1% | 36,580 | -80.4% | 0.03% | -78.9% |
| Q4 2022 | $2,213 | -99.7% | 187,029 | +72.7% | 0.12% | +215.4% |
| Q3 2022 | $641,000 | +51.2% | 108,309 | +8.7% | 0.04% | +21.9% |
| Q2 2022 | $424,000 | -33.2% | 99,670 | +716.4% | 0.03% | -82.3% |
| Q4 2020 | $635,000 | – | 12,208 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |